Inside Europe's Transgender Medicine System with Róisín Michaux
27 August 2026
With Róisín Michaux
gender-clinics
Journalist Róisín Michaux went undercover as a distressed autistic teenager to map how European gender medicine really works. What she found is less a healthcare system than a pipeline — running from online prescribers through cross-border prescribing to surgery in Madrid — whose architecture has been shaped by ideological commitment rather than clinical evidence. The episode exposes how institutions behave when consensus is manufactured and dissent is framed as harm.
Róisín Michaux is an Irish journalist based in Brussels whose investigation into European gender medicine took an unusual form. Posing as a distressed, autistic teenage girl, she navigated the network of online services, cross-border clinics, and advocacy-adjacent pathways that have become a parallel route around national health systems. What she found is not a coherent medical protocol but a loosely connected ecosystem of providers whose shared ideological commitment has come to substitute for clinical rigour. The episode opens with Ireland's fragmented provision, where the national gender service has split and young people increasingly turn to online prescribers and private clinics abroad. Michaux traces the role of services like Gender GP and Gender Plus, and examines how cross-border prescribing models have extended access across European borders with little co-ordination with the young person's home country, GP, or family. The picture is of a system that has learned to route around institutional gatekeeping rather than engage with it. The most striking finding concerns access to surgery. Making contact with clinics in Madrid willing to discuss mastectomies for minors, Michaux found that for a fictional teenager described as autistic and distressed, the pathway opened with relative ease. Most European health systems nominally require extended assessment, parental consent, and multidisciplinary oversight for such procedures. The gap between stated policy and operational reality is where the ideological dimension of this system becomes most visible. The episode also covers the surge in presentations during and after lockdown, and the failure of mental health services to develop responses outside the affirmation framework. The conversation examines how suicide risk protocols have functioned within this system — not simply as a neutral clinical safeguard but as a mechanism for accelerating access, in which declining to affirm an identity is positioned as itself creating danger. This reframing of caution as harm has had lasting effects on clinical practice. A visit to an Antwerp youth clinic and an account of the WPATH pipeline give the episode its systemic reach. What emerges is a picture of international consensus-building in which a small network of clinicians and advocacy organisations has shaped the standards now governing practice across multiple health systems. This is not a story about individual failures but about how institutions behave when ideological commitment displaces the ordinary requirement for robust evidence. The episode makes a distinctive contribution by showing how the separate components of this system — online access, cross-border prescribing, private surgery, international standards bodies — connect into something more cohesive than any single scandal. Understanding how that architecture formed, and whose interests it serves, is essential for anyone thinking seriously about what a genuinely evidence-based response to gender distress in young people would need to dismantle and rebuild.
